Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?

[1]  E. Pearce,et al.  Differentiated thyroid cancers 11-20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or =10 mm. , 2008, Thyroid : official journal of the American Thyroid Association.

[2]  I. Sugitani,et al.  Re-Evaluation of Histopathological Factors Affecting Prognosis of Differentiated Thyroid Carcinoma in an Iodine-Sufficient Country , 2010, World Journal of Surgery.

[3]  J. Shah,et al.  Patterns of failure in differentiated carcinoma of the thyroid based on risk groups , 1998, Head & neck.

[4]  T. Uruno,et al.  Thyroid Lobectomy for Papillary Thyroid Cancer: Long-term Follow-up Study of 1,088 Cases , 2013, World Journal of Surgery.

[5]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[6]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[7]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[8]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[9]  E. Kaplan,et al.  Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.

[10]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[11]  J. Shah.  Re: Extent of surgery affects papillary thyroid cancer. , 2008, Annals of surgery.

[12]  A. Belfiore,et al.  Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  R. Tuttle,et al.  Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[14]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[15]  T. Fahey,et al.  Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? , 2009, Thyroid : official journal of the American Thyroid Association.

[16]  J. Shah,et al.  Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. , 1996, American journal of surgery.

[17]  Heno . Nevotlo.  Papillary Thyroid Carcinoma: A 10 Year Follow-Up Report of the Impact of Therapy in 576 Patients , 1981 .

[18]  P. Ituarte,et al.  Effect of reoperation on outcomes in papillary thyroid cancer. , 2013, Surgery.

[19]  H. Yamashita,et al.  Papillary Microcarcinoma , 2008, World Journal of Surgery.

[20]  A. Miyauchi,et al.  Excellent Prognosis of Patients with Solitary T1N0M0 Papillary Thyroid Carcinoma Who Underwent Thyroidectomy and Elective Lymph Node Dissection Without Radioiodine Therapy , 2010, World Journal of Surgery.

[21]  J. Tward,et al.  Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer , 2011, Head & neck.

[22]  G. van Melle,et al.  Prognostic factors in papillary carcinoma of the thyroid , 1991, Cancer.

[23]  D. Urbach,et al.  Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer , 2005, Annals of surgical oncology.